Sports Science Institute of South Africa (SSISA)’s Post

Today, on #WorldMultipleSclerosisDay, we stand together to raise #awareness and support for the millions affected by MS worldwide. From understanding the complexities of #diagnosis to exploring innovative treatments and advancements in research, let's navigate multiple sclerosis together. Join the conversation, share your stories, and advocate for acceptance, inclusion, and improved healthcare for all. Together, we can make a difference. #WorldMSDay #MultipleSclerosisAwareness #NavigatingMSTogether  https://bit.ly/3KodcLO

Parkinson's disease is a progressive neurological disorder affecting movement. This blog post dives deep into the causes and symptoms of Parkinson's Disease. By raising awareness, we can provide better support to those living with Parkinson's and encourage ongoing research for effective treatments. To gain detailed insights read our latest blog. https://lnkd.in/gBKGb8QP #healthcare #NGMH #AmbujaNeotia #NeotiaGetwelMultispecialtyHospital #siliguri #healthcare #healthandwellness #Darjeeling #Jalpaiguri #health #parkinsons #parkinsonssupport #parkinsonsdisease #parkinsonsexercise

The doctor should say “You have Parkinson’s and these are the things that you can do to live better and here are some people who can support you and I’m part of your team,’” Good article! Please read it. I agree the focus should be more on positivity and lifestyle and less on only medication. My magazine support this, where you can find the tips in all the stories of people living with Parkinson's. #parkinson #Parkinson's #yopd #diagnosis #positivity #lifestyle https://lnkd.in/e9T9HxG8

As we recognize World Parkinson's Day today and Parkinson's Awareness Month, Kerri Bain, PT, DPT, shares 7 strategies that can help clinicians overcome common barriers in patients with Parkinson’s Disease. #WorldParkinsonsDay #ParkinsonsDisease

World Multiple Sclerosis Day Tomorrow is focusing on multiple sclerosis with the goal of raising awareness and research. You may know someone living with multiple sclerosis (MS).  Multiple sclerosis affects your central nervous system.  That includes your brain, spinal cord and optic nerves. It is a chronic disease.  Your central nervous system controls just about everything that you do.  The disease basically affects communication between your brain and the rest of your body. This can be a slow disease and your symptoms can vary.  Some common symptoms include: Fatigue Memory issues Mood Mobility Numbness Pain Tingling Vision impairment There are approximately  2.9 million sufferers of the disease worldwide.  Onset often occurs between the ages of 20 and 40.  Unfortunately there is little known about the origins of multiple sclerosis and it can be hard to diagnose. If you have symptoms, your health professional will use many strategies to come to a diagnosis. You may feel discouraged by all this news but there are some new treatments. The medicines won’t cure it but can help with symptoms and reduce relapses. You should speak with your medical provider but some names of medicines are Fingolimod (Gilenya), Diroximel fumarate (Vumerity), Ozanimod (Zeposia), Ofatumumab, Novartis (Kesimpta), Ponesimod (Ponvory).  These are all newly approved by the FDA. Private Home Health Care knows that multiple sclerosis is a difficult disease.  We remain hopeful that with current medicines and ongoing research the world can provide help for those who live with it. Photo by Artem Podrez

,The glass is half full‘ 🥃…. …and ,gets even fuller’ as research runs already beyond the first generation of disease modifying #treatments for #Alzheimers’ Disease. This is the opinion researchers working since decades in the field share with the many young scientists attending this years‘ AD/PD congress in Lisbon (https://shorturl.at/hzHMT) this week. 🧐 Here newest research results on Alzheimers’and Parkinson’s Disease are presented and discussed. With over 4000 international attendees the conference is a vivid prove of the importance (and attractiveness) of this topic. 🧠In service of the public and people with #dementia and their carers in Switzerland my objective attending the conference is to get the current full(er) picture of most recent developments and caveats. Since one of Alzheimer Schweiz Suisse Svizzera‘s most important mandate is to inform the public facts-based, objectively and transparently about opportunities AND risks on news concerning therapies for and care of people with dementia, this will guide our work in the context of the expected decision on the approvals of new drugs by Swissmedics. #Alzheimer #dementia #precisonmedicin #treatment

Struggling with Parkinson's disease? You're not alone, but there is hope! Discover the power of Neurophysiotherapy - a game-changer in improving quality of life for those living with Parkinson's. Dive into our website for more info: https://lnkd.in/eNAFGDgX #ParkinsonsDisease #Neurophysiotherapy

https://lnkd.in/g87442P8 - a diagnosis of #dementia is frankly one of dread for most patients and their loved ones, as the future looks bleak with the progression of the disease. However, this article from CNN describes how perhaps markers of the disease can be arrested, or even reversed, with some key changes which lead to generally #betterhealth. From basics like eating and sleeping better, and exercising more, to some targeted medications to address specific markers and risks, the picture does perhaps offer a ray of hope. What is clear though is that our understanding of the pathogenesis and progression of dementia (both #Alzheimers & #vascular) is not complete. Further work is necessary for a more universally accepted, systematic #treatment (and #prevention) protocol. #HealthyAgeing #HiddenPandemic #MentalHealth #PublicHealth

In the United States, approximately 7 million individuals are living with Alzheimer's disease and related dementias, but the number of formally diagnosed cases is significantly lower. Recent research indicates that the likelihood of receiving a formal diagnosis can vary depending on one's location. This study reveals that disparities in dementia diagnosis are not solely linked to individual risk factors but also highlight the impact of healthcare resources and disease education accessibility. Addressing the regional variations in healthcare access for diagnosis and treatment remains a critical challenge. #alzheimerdisease #healthcareaccess

Lewy Body Dementia (LBD) is a complex condition marked by abnormal protein deposits in the brain, leading to symptoms that affect cognitive functions, movement, and behavior. This disorder, encompassing dementia with Lewy bodies and Parkinson's disease dementia, presents significant challenges in diagnosis and treatment. Ongoing research is vital for uncovering the intricacies of LBD, with the goal of improving diagnostic accuracy and finding more effective treatments to enhance patient care. #HeadlandsResearch #LewyBodyDementia #LBD For more information visit https://lnkd.in/drcDUxin